Intercept Pharmaceuticals Banner Image

Intercept Pharmaceuticals

  • Ticker ICPT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intercept Pharmaceuticals Logo Image
  • 201-500 Employees
  • Based in New York City, New York
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.
4.7 / 5.0 (121)

Intercept Pharmaceuticals reports have an aggregate usefulness score of 4.7 based on 121 reviews.

Intercept Pharmaceuticals

Most Recent Annual Report

Intercept Pharmaceuticals
MOST RECENT 2022 Annual Report and Form 10K

Intercept Pharmaceuticals does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Intercept Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!